Annovis Bio, Inc. (ANVS) Operating cash flow 2019–2025
Annovis Bio, Inc. (ANVS) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$25.6MFY2025 · since FY2019: -$476,542 → -$25.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$25.6M | -17.0% |
| FY2024 | -$21.9M | +45.2% |
| FY2023 | -$40.0M | -130.9% |
| FY2022 | -$17.3M | -89.6% |
| FY2021 | -$9.1M | -130.0% |
| FY2020 | -$4.0M | -733.3% |
| FY2019 | -$476,542 | — |
Source: SEC XBRL filings · For reference only · Not investment advice